Lamifungin gel naruzhn.prim-I 1% 15g

$5.23

Lamifungin gel naruzhn.prim-I 1% 15g

Quantity:

SKU: 01279098437 Categories: , , Tag:

Description

Composition
Active substance:
100 g of gel contains: terbinafine hydrochloride (calculated as 100% dry substance terbinafine) – 1 g
Excipients:
butylhydroxytoluene; benzyl alcohol (in terms of 100% substance); sorbitan laurate, polysorbate 20; isopropyl; Ethanol (etilovyyspirt) 95%; Carbomer (Carbopol 974P) (based on suhoeveschestvo); sodium hydroxide; purified water.
Description:
Gel white or almost white color with a faint characteristic odor.
Product form:
Gel for external application of 1%.
15 g, 30 g and 50 g of aluminum into a tube. The tube together with instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity to terbinafine or to the components of the preparation, breastfeeding, children under 18 years.
Carefully.
Caution must be exercised when applying the drug to damaged skin because of the gel auxiliaries – benzyl alcohol, ethanol – may cause irritation.
Dosage
10 mg / g
Indications
Prevention and treatment of fungal infections of the skin, including foot mycoses ( “mushroom” of the foot), jock itch (tinea cruris), fungal infections of the skin smooth body (tinea corporis), caused by dermatophytes such as Trichophyton (including, T. rubrum , T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum. Pityriasis versicolor (Pityriasis versicolor), caused by Pityrosporum orbiculare (also known as Malassezia furfur).
Interaction with other drugs
Drug interaction terbinafine for external use has not been studied.
Overdose
Due to the low systemic absorption when applied externally overdose unlikely. If the drug is ingested accidentally, you can expect the appearance of the same symptoms that occur with an overdose of terbinafine tablets: headache, nausea, gastralgia, dizziness.
Treatment: administration of activated charcoal, if necessary – symptomatic supportive therapy
pharmachologic effect
Pharmacological group:
Antifungal agent.
Pharmacodynamics:
Terbinafine is an allylamine, which has a broad spectrum of activity against fungi including dermatophytes such as Trichophyton (e.g., Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton violaceum, Trichophyton tonsurans), Microsporum (e.g., Microsporum canis) Epidermophyton floccosum and yeast fungi of the genus Candida (eg Candida albicans) and Malassezia.
Terbinafine specifically alters the early stage of the biosynthesis of sterols, occurring in fungi. This leads to a deficiency of ergosterol and to an intracellular accumulation of squalene, which causes death of fungal cells. Action terbinafine accomplished by inhibition of the enzyme squalene epoxidase located on the cell membrane of the fungus. Terbinafine has no effect on cytochrome P450 system in humans and, accordingly, the metabolism of hormones or other drugs.
Pharmacokinetics:
When applied topically the drug rapidly penetrates the dermal layer of the skin and accumulate in the stratum corneum, nails and hair in, absorption of terbinafine is less than 5% has little systemic effect. When applied topically can not exclude the potential revenues of the drug in breast milk
Pregnancy and breast-feeding
In experimental animal studies, teratogenic properties of terbinafine have been identified. To date, no reports of any malformations with topical terbinafine. However, as clinical experience with the drug in pregnant women is limited, its application is possible if the expected benefit to the mother outweighs the potential risk to the fetus.
Terbinafine is excreted in breast milk, so the drug should not be applied to nursing mothers. Do not allow contact with the infant skin surface treated with gel Lamifungin®.
Conditions of supply of pharmacies
Without recipe.
side effects
Classification side reactions organs and systems indicating the frequency of occurrence: very often (> 1/10), often (> 1/100
special instructions
Lamifungin® gel for topical application of 1% is intended for external use only. Reducing the severity of the clinical manifestations usually noted in the first days of treatment.
In the case of irregular or premature treatment termination increases the risk of disease recurrence. If after 2 weeks of treatment shows no sign of improvement, should be re-identify the causative agent and its sensitivity to the drug.
In applying the drug Lamifungin® gel for external application of 1% should observe good personal hygiene to prevent re-infection through underwear or shoes. During and at the end of treatment should be carried out anti-fungal treatment of shoes, socks, underwear.
The drug should not be applied to the face.
The preparation contains butylhydroxytoluene, which might cause a local application of local allergic reactions (contact dermatitis). Caution must be exercised when applying the drug on the damaged areas of skin have been included in the gel excipients (benzyl alcohol, ethanol) may cause skin irritation.
Avoid exposure of the drug to eyes, nose, mouth. After contact with the gel in the eye they must be rinsed with water and, if persistent irritation should consult a physician.
Effects on ability to drive vehicles, machinery.
The drug does not affect the ability to drive vehicles or to engage in other potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
At a temperature not exceeding 25 C. Do not freeze. Keep out of the reach of children.
Dosing and Administration
Outwardly.
Adults and children over 18 years.
Before using the product Lamifungin® gel for external application of 1% must be thoroughly clean and dry the affected area. Gel gently rubbed into the affected sites as well as the adjacent intact skin. In case of infections involving diaper rash (under the breasts, between the fingers, in the gluteal folds and inguinal) area of ​​application of the gel can be covered with gauze, especially at night.
The duration of treatment and the multiplicity of the drug:
Ringworm of the body, legs: 1 week – 1 per day.
Tinea pedis ( “foot fungus”): 1 week – 1 time per day.
Jock itch: 1-2 weeks – 1 time per day.
Pityriasis versicolor: 1 week – 1 per day.
The duration of treatment depends on the indication and the severity of the disease.
Elderly patients: no need to change dosage regimen in the elderly. Reducing the severity of the clinical manifestations usually noted in the first days of treatment.
In the case of irregular or premature treatment termination are at risk of recurrent infection. If after two weeks of treatment shows no sign of improving, you should verify the diagnosis.
Use according to preparation method and application in the doses indicated in the instructions for use. If necessary, please consult your physician before using the drug.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

TATHIMFARM

There are no reviews yet.

Add your review